(Q28285819)

1

0 references

L D Dikkeschei

2

0 references

N H Mulder

3

0 references

E van der Ploeg

4

0 references

D T Sleijfer

5

0 references

E G de Vries

European Journal of Cancer & Clinical Oncology

6

0 references

language of work or name

English

0 references

publication date

March 1988

0 references

published in

0 references

volume

24

0 references

issue

3

0 references

page(s)

417-21

0 references

cites work

Behandlung des Hirsutismus mit Cyproteronacetat*

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990011-6

7 January 2021

Experience in the Treatment of Prostatic Carcinoma with Cyproterone Acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990011-6

7 January 2021

Cyproteroneacetate and ACTH Adrenal Function*

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990011-6

7 January 2021

Cyproterone acetate in the treatment of metastatic cancer of the male breast

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990011-6

7 January 2021

Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990011-6

7 January 2021

Progesterone oral contraception and blood coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990011-6

7 January 2021

Hepatocellular damage by cyproterone acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990011-6

7 January 2021

Pharmacokinetic Consequences of Aging

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990011-6

7 January 2021

Bio-availability and pharmacokinetics of cyproterone acetate-14C and ethinyloestradiol-3H after oral administration as a coated tablet (SH B 209 AB)

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990011-6

7 January 2021

Plasma Levels of Active Ingredients After Single and Repeated Administration of a New Oral Contraceptive Containing 2 Mg of Cyproterone Acetate and 50 μg of Ethinyl Estradiol (Diane®) to Five Young Women

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990011-6

7 January 2021

Adrenal suppression by oral high-dose medroxyprogesterone acetate in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990011-6

7 January 2021

Aromatase, 17 beta-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990011-6

7 January 2021